Vulnerable patients facing social, environmental, and economic disadvantages often experience worse cancer outcomes than other groups. Some of these disparities may be reduced by increasing access to hospitals accredited by the American College of Surgeons (ACS) Commission on Cancer (CoC), according to a study. The study found highly vulnerable patients treated at CoC-accredited hospitals, as measured by the Centers for Disease Control and Prevention (CDC) Social Vulnerability Index (SVI), were more likely to receive care that adhered to national treatment guidelines and were 9% less likely to die than patients treated at non-CoC-accredited hospitals during the study period. These results...